January 8, 2018 / 1:21 PM / 6 months ago

BRIEF-AMAG Pharmaceuticals Sees Q4 2017 Revenue $156 Mln to $163 Mln

Jan 8 (Reuters) - AMAG Pharmaceuticals Inc:

* AMAG PHARMACEUTICALS ANNOUNCES PRELIMINARY 2017 FINANCIAL RESULTS AND PROVIDES 2018 GUIDANCE

* SEES Q4 2017 REVENUE UP ABOUT 5 PERCENT

* - ‍FOR Q4 OF 2017, AMAG EXPECTS AN OPERATING LOSS OF BETWEEN $6 MILLION AND $16 MILLION​

* - ‍EXPECTS 2017 TOTAL GAAP REVENUE TO BE BETWEEN $607 MILLION AND $614 MILLION​

* SEES ‍ 2017 OPERATING LOSS OF BETWEEN $292 MILLION AND $302 MILLION (DUE PRIMARILY TO A Q3 NON-CASH ACCOUNTING CHARGE)​

* SEES ‍2018 TOTAL GAAP REVENUE $500 MILLION - $560 MILLION​

* SEES ‍2018 GAAP OPERATING LOSS $147 MILLION - $117 MILLION​

* Q4 REVENUE VIEW $161.1 MILLION — THOMSON REUTERS I/B/E/S

* FY2017 REVENUE VIEW $616.0 MILLION — THOMSON REUTERS I/B/E/S

* FY2018 REVENUE VIEW $504.1 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below